Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug databases and their contributions to drug repurposing
Yosef Masoudi-Sobhanzadeh, Yadollah Omidi, Massoud Amanlou, et al.
Genomics (2019) Vol. 112, Iss. 2, pp. 1087-1095
Open Access | Times Cited: 102

Showing 1-25 of 102 citing articles:

Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 93
A review of biomedical datasets relating to drug discovery: a knowledge graph perspective
Stephen Bonner, Ian P. Barrett, Cheng Ye, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 6
Open Access | Times Cited: 84
Machine learning in drug design: Use of artificial intelligence to explore the chemical structure–biological activity relationship
Maciej Staszak, Katarzyna Staszak, Karolina Wieszczycka, et al.
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 89
Artificial Intelligence in Drug Discovery: A Comprehensive Review of Data-driven and Machine Learning Approaches
Hyunho Kim, Eun‐Young Kim, Ingoo Lee, et al.
Biotechnology and Bioprocess Engineering (2020) Vol. 25, Iss. 6, pp. 895-930
Open Access | Times Cited: 82
Computational Insights on the Potential of Some NSAIDs for Treating COVID-19: Priority Set and Lead Optimization
Ayman Abo Elmaaty, Maha M. Abdel‐Fattah, Muhammad I. Ismail, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3772-3772
Open Access | Times Cited: 72
Deep Learning in Drug Target Interaction Prediction: Current and Future Perspectives
Karim Abbasi, Parvin Razzaghi, Antti Poso, et al.
Current Medicinal Chemistry (2020) Vol. 28, Iss. 11, pp. 2100-2113
Closed Access | Times Cited: 71
Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study
Ayman Abo Elmaaty, Radwan Alnajjar, Maha M. Abdel‐Fattah, et al.
RSC Advances (2021) Vol. 11, Iss. 17, pp. 10027-10042
Open Access | Times Cited: 61
MHTAN-DTI: Metapath-based hierarchical transformer and attention network for drug–target interaction prediction
Ran Zhang, Zhanjie Wang, Xuezhi Wang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 30
Drug Repurposing: A Leading Strategy for New Threats and Targets
Ashish Sriram Mishra, V Manimaran, Sivakumar Ponnurengam Malliappan
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 4, pp. 915-932
Open Access | Times Cited: 11
GraphsformerCPI: Graph Transformer for Compound–Protein Interaction Prediction
Jun Ma, Zhili Zhao, Tongfeng Li, et al.
Interdisciplinary Sciences Computational Life Sciences (2024) Vol. 16, Iss. 2, pp. 361-377
Closed Access | Times Cited: 8
A multimodal deep learning-based drug repurposing approach for treatment of COVID-19
Seyed Aghil Hooshmand, Mohadeseh Zarei Ghobadi, Seyyed Emad Hooshmand, et al.
Molecular Diversity (2020) Vol. 25, Iss. 3, pp. 1717-1730
Open Access | Times Cited: 59
A review of machine learning approaches for drug synergy prediction in cancer
Anna Torkamannia, Yadollah Omidi, Reza Ferdousi
Briefings in Bioinformatics (2022) Vol. 23, Iss. 3
Closed Access | Times Cited: 36
Deciphering the Lexicon of Protein Targets: A Review on Multifaceted Drug Discovery in the Era of Artificial Intelligence
Suvendu Nandi, Soumyadeep Bhaduri, Debraj Das, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 4, pp. 1563-1590
Closed Access | Times Cited: 7
Halicin: A New Horizon in Antibacterial Therapy against Veterinary Pathogens
Shuge Wang, Zhao Ke, Ziqi Chen, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 492-492
Open Access | Times Cited: 5
Special Issue “Advances in Drug Discovery and Synthesis”
Lidia Ciccone, Susanna Nencetti
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 584-584
Open Access
Old drugs, new challenges: reassigning drugs for cancer therapies
Paulina Czechowicz, Anna Więch-Walów, Jakub Sławski, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access
Comprehensive Analysis of MAGE-A10 in Pan-Cancer and Its Validation in Gastric Cancer
Yichen Yin, Baozhen Wang, Mingzhe Yang, et al.
Research Square (Research Square) (2025)
Closed Access
A Review of Drug-Target Interaction Prediction Methods
Hongtao Yu, Yin Wang, Jungang Lou
Communications in computer and information science (2025), pp. 161-195
Closed Access
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
Igor José dos Santos Nascimento, Thiago Mendonça de Aquino, Edeildo Ferreira da Silva‐Júnior
Current Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 2887-2942
Closed Access | Times Cited: 34
Network for network concept offers new insights into host- SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
Neda Eskandarzade, Abozar Ghorbani, Samira Samarfard, et al.
Computers in Biology and Medicine (2022) Vol. 146, pp. 105575-105575
Open Access | Times Cited: 19
Advances in the computational landscape for repurposed drugs against COVID-19
Illya Aronskyy, Yosef Masoudi-Sobhanzadeh, Antonio Cappuccio, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 12, pp. 2800-2815
Open Access | Times Cited: 26
Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches
Merve Çakır, Kirsten Obernier, Antoine Forget, et al.
mSystems (2021) Vol. 6, Iss. 5
Open Access | Times Cited: 23
The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
Ángel M. Cuesta, Eunate Gallardo‐Vara, Juan Casado‐Vela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4217-4217
Open Access | Times Cited: 17
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
Arief Rahman Afief, Lalu Muhammad Irham, Wirawan Adikusuma, et al.
Biochemistry and Biophysics Reports (2022) Vol. 32, pp. 101337-101337
Open Access | Times Cited: 17
Machine learning for drug repositioning: Recent advances and challenges
Lijun Cai, Jiaxin Chu, Junlin Xu, et al.
Current Research in Chemical Biology (2023) Vol. 3, pp. 100042-100042
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top